Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS

Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis Jr. and U. Kristina Walle
Drug Metabolism and Disposition December 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885
Thomas Walle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faye Hsieh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark H. DeLegge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John E. Oatis Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
U. Kristina Walle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 12 1377-1382
DOI 
https://doi.org/10.1124/dmd.104.000885
PubMed 
15333514

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 7, 2004
  • Accepted August 26, 2004
  • Published online November 18, 2004.

Article Versions

  • Earlier version (August 27, 2004 - 12:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Thomas Walle,
  2. Faye Hsieh,
  3. Mark H. DeLegge,
  4. John E. Oatis, Jr. and
  5. U. Kristina Walle
  1. Department of Cell and Molecular Pharmacology and Experimental Therapeutics (T.W., J.E.O., U.K.W.) and Digestive Disease Center (M.H.D.), Medical University of South Carolina, Charleston, South Carolina; and Amgen, Inc., Thousand Oaks, California (F.H.)
  1. Address correspondence to:
    Dr. Thomas Walle, Dept. of Pharmacology, Medical University of South Carolina, 173 Ashley Avenue, P.O. Box 250505, Charleston, SC 29425. E-mail: wallet{at}musc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to February 2023

AbstractFullPdf
Aug 20177223254
Sep 20178724660
Oct 20177228853
Nov 20178938165
Dec 20178225745
Jan 201810125765
Feb 20186126777
Mar 20184629474
Apr 20185628666
May 201867323112
Jun 20186931171
Jul 201816346161
Aug 201810407108
Sep 20182400106
Oct 20184443179
Nov 201811380160
Dec 201825097101
Jan 2019356968
Feb 20193652144
Mar 20193232426
Apr 20193202031
May 20193121419
Jun 20193081529
Jul 20193721633
Aug 20192271321
Oct 20193322029
Nov 2019286269
Dec 2019278145
Jan 2020206165
Feb 2020332168
Mar 2020250188
May 202026494
Jun 202021674
Jul 202017165
Aug 202014377
Sep 2020226177
Oct 2020242128
Nov 202024992
Dec 2020236166
Jan 2021284286
Feb 2021219179
Mar 2021322158
Apr 2021367121
May 20212771511
Jun 2021280189
Jul 202131783
Aug 2021306153
Sep 2021242135
Oct 2021326149
Nov 202129283
Dec 2021289129
Jan 202222674
Feb 202225332
Mar 202232484
Apr 2022232249
May 2022253134
Jun 202220185
Jul 2022258138
Aug 202224197
Sep 202230563
Oct 2022268177
Nov 202234094
Dec 2022240177
Jan 2023307142
Feb 2023500

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (12)
Drug Metabolism and Disposition
Vol. 32, Issue 12
1 Dec 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS

Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis and U. Kristina Walle
Drug Metabolism and Disposition December 1, 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS

Thomas Walle, Faye Hsieh, Mark H. DeLegge, John E. Oatis and U. Kristina Walle
Drug Metabolism and Disposition December 1, 2004, 32 (12) 1377-1382; DOI: https://doi.org/10.1124/dmd.104.000885
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Series-Compartment Models of Hepatic Elimination
  • Warfarin PBPK Model with TMDD Mechanism
  • Identification of payload-containing catabolites of ADCs
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics